Literature DB >> 3083405

Is schizophrenia a viral or immunologic disorder?

L E DeLisi, T J Crow.   

Abstract

The literature that schizophrenia may be a viral or immunologic disorder is reviewed. Although these hypotheses were formulated more than half a century ago, researchers have failed to establish clear evidence for their support. Nevertheless, epidemiologic issues addressed in this article provide impetus for further pursuit of research in this area.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083405

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  11 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Autoantibodies to brain and polynucleotides in patients with schizophrenia: a puzzle.

Authors:  H A Teplizki; B Sela; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

3.  T-lymphocyte subpopulations in schizophrenic patients.

Authors:  A Henneberg; B Riedl; H O Dumke; H H Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

4.  Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants.

Authors:  Jubao Duan; Alan R Sanders; Winton Moy; Eugene I Drigalenko; Eric C Brown; Jessica Freda; Catherine Leites; Harald H H Göring; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2015-05-28       Impact factor: 6.150

5.  Antibodies to brain tissue in sera of schizophrenic patients--preliminary findings.

Authors:  A E Henneberg; S Ruffert; H J Henneberg; H H Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.

Authors:  D G Kirch; R C Alexander; R L Suddath; N M Papadopoulos; C A Kaufmann; D G Daniel; R J Wyatt
Journal:  J Neural Transm Gen Sect       Date:  1992

7.  Failure to detect dopamine receptor IgG autoantibodies in sera of schizophrenic patients. Short note.

Authors:  A von Kirchbach; E G Fischer; H H Kornhuber
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 8.  Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics.

Authors:  Nicole Moschny; Gudrun Hefner; Renate Grohmann; Gabriel Eckermann; Hannah B Maier; Johanna Seifert; Johannes Heck; Flverly Francis; Stefan Bleich; Sermin Toto; Catharina Meissner
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

9.  The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study.

Authors:  Lot D de Witte; Hans C van Mierlo; Manja Litjens; Hans C Klein; Sabine Bahn; Ab D Osterhaus
Journal:  NPJ Schizophr       Date:  2015-11-04

10.  The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review.

Authors:  Alessandro Cuomo; Giuseppe Maina; Gianluca Rosso; Bruno Beccarini Crescenzi; Simone Bolognesi; Angela Di Muro; Nicola Giordano; Arianna Goracci; Stephen M Neal; Maria Nitti; Fulvio Pieraccini; Andrea Fagiolini
Journal:  Front Pharmacol       Date:  2018-10-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.